Hepatitis C Treatment with First-Generation Protease Inhibitors in A Real-World Cohort- Risk-Benefit Profile and Costs of the Therapy
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.954
https://www.valueinhealthjournal.com/article/S1098-3015(16)32320-8/fulltext
Title :
Hepatitis C Treatment with First-Generation Protease Inhibitors in A Real-World Cohort- Risk-Benefit Profile and Costs of the Therapy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32320-8&doi=10.1016/j.jval.2016.09.954
First page :
A511
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
898